Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

HSA Approval

GLYBORAL TABLET 5 mg

Approval Number

SIN11789P

Drug Name

GLYBORAL TABLET 5 mg

Product Name

GLYBORAL TABLET 5 mg

Approval Date

January 26, 2002

Registrant

ZYFAS MEDICAL CO

Licence Holder

ZYFAS MEDICAL CO

Regulatory Information

Registrant

ZYFAS MEDICAL CO

Licence Holder

ZYFAS MEDICAL CO

Drug Type

Therapeutic

Forensic Classification

Prescription Only

Formulation Information

Dosage Form

TABLET

Route of Administration

ORAL

Medical Information

ATC Code

A10BB01

ATC Item Name

glibenclamide

Manufacturer Information

Pharmaceutical Manufacturer

ZYFAS MEDICAL CO

Manufacturers

USV LIMITED

Active Ingredients

Ingredient Name

GLIBENCLAMIDE

Strength

5 mg

Drug MonographGlyburide

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

GLYBORAL TABLET 5 mg - HSA Approval | MedPath